Traitement Cancer rectal en Israël — recevez 3 correspondances personnalisées de cliniques

Israeli oncology centers achieve 80–90% sphincter preservation for mid and high rectal tumors. Modern surgical techniques like low anterior resection (LAR) often avoid a permanent colostomy bag. The necessity depends on tumor location, response to preoperative therapy, and whether the anal sphincter remains functional.

• Sphincter preservation: Surgeons prioritize saving anal muscles in 80–90% of mid-rectal cases.
• Tumor distance: Tumors under 6 cm from the anus carry higher permanent bag risk.
• Temporary ileostomy: Most patients use a temporary bag for 8–12 weeks during healing.
• Watch-and-wait: Complete response to chemoradiation may allow for monitoring without any surgery.

Bookimed Expert Insight: Data shows that choosing high-volume centers like Sourasky Medical Center, which performs 34,000+ annual operations, significantly increases the chance of sphincter-saving surgery. Experienced surgeons like Dr. Hagit Tulchinsky specialize in restorative proctectomy. This reconstruction technique is a key factor in avoiding a permanent bag even for low-seated tumors.

Patient Consensus: Patients note that strong tumor shrinkage after initial radiation often changes the surgical plan from a permanent bag to a temporary one. Many emphasize that a successful 12-week recovery usually leads to a straightforward reversal procedure.

Israel provides advanced rectal cancer surgeries focused on sphincter preservation and precision. Leading centers like Sourasky and Sheba utilize the da Vinci robotic system for complex resections. Available techniques include Transanal Total Mesorectal Excision (TaTME) and HIPEC for treating advanced or metastatic cases.

• Robotic-assisted surgery: Surgeons use da Vinci systems for high-precision resections in narrow pelvic areas.
• Transanal techniques: TaTME and TEM allow tumor removal through the anus to avoid external incisions.
• Sphincter-sparing procedures: Intersphincteric resection (ISR) helps patients maintain bowel control without a permanent bag.
• Advanced chemotherapy: HIPEC delivers heated drugs directly into the abdomen during surgery for metastatic disease.

Bookimed Expert Insight: Israeli oncology centers demonstrate high capability for complex cases, evidenced by the 14-night hospital stays included in Sourasky’s HIPEC packages. This extended monitoring period exceeds standard surgical recovery times, reflecting a focus on managing high-intensity treatments like cytoreductive surgery. This long-term inpatient care is a key differentiator for international patients seeking safety in major oncological procedures.

Patient Consensus: Patients emphasize the value of robotic-assisted options for preserving natural function and avoiding a permanent colostomy. Many note that getting a remote second opinion from Israeli specialists helps clarify if organ-preserving techniques like TEM are viable for their specific stage.

Advanced rectal cancer treatment in Israel focuses on molecular profiling and aggressive regional therapies. Patients access innovative options like MSI-H/dMMR immunotherapy, BRAF-targeted triplet regimens, and HIPEC. Specialist centers utilize robotic systems and CyberKnife for precise tumor destruction in metastatic cases.

• Molecular targeting: Doctors use tumor sequencing to identify KRAS, BRAF, and HER2 mutations.
• Immunotherapy: Keytruda (Pembrolizumab) or Opdivo are standard for tumors with high microsatellite instability.
• Regional therapy: HIPEC at centers like Sourasky treats peritoneal spread with heated chemotherapy.
• Robotic precision: Da Vinci systems enable restorative surgeries, preserving bowel function and nerves.

Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba often combine high-volume surgical expertise with molecular research. For instance, Dr. Joseph Klauzner has over 45 years of experience in complex colorectal cases. This experience is vital because successful metastatic treatment often requires a custom sequence of SIRT, HIPEC, and biological drugs.

Patient Consensus: Patients emphasize the necessity of biomarker testing for KRAS and BRAF before starting any systemic treatment. Many note that seeking a second opinion from high-volume hepatic surgeons is crucial if the cancer has spread to the liver.

Top treatment centers for rectal cancer in Israel are located in Tel Aviv, Ramat Gan, and Jerusalem. These JCI-accredited facilities include Sheba Medical Center and Sourasky Medical Center. Both rank among the top 10 hospitals globally according to Newsweek. They offer advanced robotic surgery and personalized oncology protocols.

• Sheba Medical Center: Ranked top 10 globally. Located in Ramat Gan near Tel Aviv.
• Sourasky Medical Center: Reports a 90% oncology success rate. Located in central Tel Aviv.
• Hadassah Medical Center: Jerusalem-based center recognized by Newsweek for excellence in oncology.
• Assuta Medical Center: Largest private hospital in Tel Aviv. Offers minimal wait times for surgery.

Bookimed Expert Insight: While many choose Tel Aviv for its concentration of top-ranked clinics, Sheba Medical Center in Ramat Gan offers a unique City of Health model. It operates 6 specialized hospitals on one campus. This allows rectal cancer patients to access CAR-T therapy, TIL immunotherapies, and complex robotic resections in a single integrated location, which is rare even among the world's most elite medical institutions.

Patient Consensus: Patients note the efficiency of the international departments in Israel. They often mention that diagnostic results, which can take weeks elsewhere, are frequently completed in 3 to 5 days.